vs
ADMA BIOLOGICS, INC.（ADMA）与AMPCO PITTSBURGH CORP（AP）财务数据对比。点击上方公司名可切换其他公司
ADMA BIOLOGICS, INC.的季度营收约是AMPCO PITTSBURGH CORP的1.3倍（$139.2M vs $104.4M），ADMA BIOLOGICS, INC.净利率更高（35.5% vs -55.2%，领先90.7%），ADMA BIOLOGICS, INC.同比增速更快（18.4% vs 11.5%），ADMA BIOLOGICS, INC.自由现金流更多（$34.6M vs $-64.0K），过去两年ADMA BIOLOGICS, INC.的营收复合增速更高（30.4% vs -2.6%）
ADMA生物制剂公司是一家专注于研发、生产及商业化特种血浆来源免疫球蛋白疗法的生物制药企业，主要面向美国市场，为原发性免疫缺陷及其他免疫相关疾病患者、医护人员和医疗机构提供免疫健康领域的治疗方案。
安普科匹兹堡公司是一家特种钢材制造商，总部位于宾夕法尼亚州匹兹堡市中心，1929年由多家此前已成立的小型钢铁企业合并组建而成。需要注意区分它和其他同样带有Ampco名称的企业，比如位于密尔沃基的铜基合金生产商、迈阿密的橱柜企业等。
ADMA vs AP — 直观对比
营收规模更大
ADMA
是对方的1.3倍
$104.4M
营收增速更快
ADMA
高出6.9%
11.5%
净利率更高
ADMA
高出90.7%
-55.2%
自由现金流更多
ADMA
多$34.6M
$-64.0K
两年增速更快
ADMA
近两年复合增速
-2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $139.2M | $104.4M |
| 净利润 | $49.4M | $-57.7M |
| 毛利率 | 63.8% | — |
| 营业利润率 | 45.1% | -54.0% |
| 净利率 | 35.5% | -55.2% |
| 营收同比 | 18.4% | 11.5% |
| 净利润同比 | -55.9% | -1958.9% |
| 每股收益（稀释后） | $0.20 | $-2.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADMAAP
| Q4 25 | $139.2M | $104.4M | ||
| Q3 25 | $134.2M | $103.7M | ||
| Q2 25 | $122.0M | $108.9M | ||
| Q1 25 | $114.8M | $99.2M | ||
| Q4 24 | $117.5M | $93.6M | ||
| Q3 24 | $119.8M | $92.1M | ||
| Q2 24 | $107.2M | $107.1M | ||
| Q1 24 | $81.9M | $110.0M |
净利润ADMAAP
| Q4 25 | $49.4M | $-57.7M | ||
| Q3 25 | $36.4M | $-2.2M | ||
| Q2 25 | $34.2M | $-7.3M | ||
| Q1 25 | $26.9M | $1.1M | ||
| Q4 24 | $111.9M | $3.1M | ||
| Q3 24 | $35.9M | $-2.0M | ||
| Q2 24 | $32.1M | $2.0M | ||
| Q1 24 | $17.8M | $-2.7M |
毛利率ADMAAP
| Q4 25 | 63.8% | — | ||
| Q3 25 | 56.3% | — | ||
| Q2 25 | 55.1% | — | ||
| Q1 25 | 53.2% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 49.8% | — | ||
| Q2 24 | 53.6% | — | ||
| Q1 24 | 47.8% | — |
营业利润率ADMAAP
| Q4 25 | 45.1% | -54.0% | ||
| Q3 25 | 38.0% | 1.1% | ||
| Q2 25 | 35.1% | -2.8% | ||
| Q1 25 | 30.4% | 3.9% | ||
| Q4 24 | 32.6% | 5.5% | ||
| Q3 24 | 33.1% | 2.0% | ||
| Q2 24 | 36.6% | 4.7% | ||
| Q1 24 | 26.7% | 0.1% |
净利率ADMAAP
| Q4 25 | 35.5% | -55.2% | ||
| Q3 25 | 27.1% | -2.1% | ||
| Q2 25 | 28.1% | -6.7% | ||
| Q1 25 | 23.4% | 1.2% | ||
| Q4 24 | 95.2% | 3.3% | ||
| Q3 24 | 30.0% | -2.1% | ||
| Q2 24 | 29.9% | 1.9% | ||
| Q1 24 | 21.7% | -2.5% |
每股收益（稀释后）ADMAAP
| Q4 25 | $0.20 | $-2.87 | ||
| Q3 25 | $0.15 | $-0.11 | ||
| Q2 25 | $0.14 | $-0.36 | ||
| Q1 25 | $0.11 | $0.06 | ||
| Q4 24 | $0.45 | $0.16 | ||
| Q3 24 | $0.15 | $-0.10 | ||
| Q2 24 | $0.13 | $0.10 | ||
| Q1 24 | $0.08 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $87.6M | $10.7M |
| 总债务越低越好 | $72.1M | $117.9M |
| 股东权益账面价值 | $477.3M | $32.6M |
| 总资产 | $624.2M | $495.4M |
| 负债/权益比越低杠杆越低 | 0.15× | 3.61× |
8季度趋势，按日历期对齐
现金及短期投资ADMAAP
| Q4 25 | $87.6M | $10.7M | ||
| Q3 25 | $61.4M | $15.0M | ||
| Q2 25 | $90.3M | $9.9M | ||
| Q1 25 | $71.6M | $7.1M | ||
| Q4 24 | $103.1M | $15.4M | ||
| Q3 24 | $86.7M | $11.8M | ||
| Q2 24 | $88.2M | $7.9M | ||
| Q1 24 | $45.3M | $10.8M |
总债务ADMAAP
| Q4 25 | $72.1M | $117.9M | ||
| Q3 25 | $72.4M | $119.0M | ||
| Q2 25 | — | $115.9M | ||
| Q1 25 | — | $115.0M | ||
| Q4 24 | $72.3M | $116.4M | ||
| Q3 24 | — | $116.0M | ||
| Q2 24 | — | $119.4M | ||
| Q1 24 | — | $116.2M |
股东权益ADMAAP
| Q4 25 | $477.3M | $32.6M | ||
| Q3 25 | $431.2M | $60.1M | ||
| Q2 25 | $398.3M | $62.7M | ||
| Q1 25 | $373.4M | $64.6M | ||
| Q4 24 | $349.0M | $58.9M | ||
| Q3 24 | $231.9M | $61.3M | ||
| Q2 24 | $188.3M | $58.0M | ||
| Q1 24 | $153.7M | $56.3M |
总资产ADMAAP
| Q4 25 | $624.2M | $495.4M | ||
| Q3 25 | $568.7M | $524.4M | ||
| Q2 25 | $558.4M | $537.2M | ||
| Q1 25 | $510.6M | $536.2M | ||
| Q4 24 | $488.7M | $530.9M | ||
| Q3 24 | $390.6M | $547.4M | ||
| Q2 24 | $376.4M | $560.8M | ||
| Q1 24 | $350.9M | $565.8M |
负债/权益比ADMAAP
| Q4 25 | 0.15× | 3.61× | ||
| Q3 25 | 0.17× | 1.98× | ||
| Q2 25 | — | 1.85× | ||
| Q1 25 | — | 1.78× | ||
| Q4 24 | 0.21× | 1.98× | ||
| Q3 24 | — | 1.89× | ||
| Q2 24 | — | 2.06× | ||
| Q1 24 | — | 2.06× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.6M | $2.7M |
| 自由现金流经营现金流 - 资本支出 | $34.6M | $-64.0K |
| 自由现金流率自由现金流/营收 | 24.8% | -0.1% |
| 资本支出强度资本支出/营收 | 0.8% | 2.7% |
| 现金转化率经营现金流/净利润 | 0.72× | — |
| 过去12个月自由现金流最近4个季度 | $27.8M | $-8.1M |
8季度趋势，按日历期对齐
经营现金流ADMAAP
| Q4 25 | $35.6M | $2.7M | ||
| Q3 25 | $13.3M | $6.3M | ||
| Q2 25 | $21.1M | $-2.3M | ||
| Q1 25 | $-19.7M | $-5.3M | ||
| Q4 24 | $50.2M | $7.5M | ||
| Q3 24 | $25.0M | $11.4M | ||
| Q2 24 | $45.6M | $-5.3M | ||
| Q1 24 | $-2.2M | $4.5M |
自由现金流ADMAAP
| Q4 25 | $34.6M | $-64.0K | ||
| Q3 25 | $-1.1M | $3.3M | ||
| Q2 25 | $18.7M | $-3.8M | ||
| Q1 25 | $-24.4M | $-7.5M | ||
| Q4 24 | $47.5M | $3.7M | ||
| Q3 24 | $24.0M | $8.4M | ||
| Q2 24 | $43.6M | $-8.0M | ||
| Q1 24 | $-4.6M | $1.7M |
自由现金流率ADMAAP
| Q4 25 | 24.8% | -0.1% | ||
| Q3 25 | -0.8% | 3.2% | ||
| Q2 25 | 15.3% | -3.5% | ||
| Q1 25 | -21.2% | -7.5% | ||
| Q4 24 | 40.4% | 4.0% | ||
| Q3 24 | 20.0% | 9.1% | ||
| Q2 24 | 40.7% | -7.5% | ||
| Q1 24 | -5.6% | 1.5% |
资本支出强度ADMAAP
| Q4 25 | 0.8% | 2.7% | ||
| Q3 25 | 10.7% | 2.9% | ||
| Q2 25 | 2.0% | 1.3% | ||
| Q1 25 | 4.1% | 2.2% | ||
| Q4 24 | 2.3% | 4.0% | ||
| Q3 24 | 0.9% | 3.2% | ||
| Q2 24 | 1.9% | 2.5% | ||
| Q1 24 | 2.9% | 2.6% |
现金转化率ADMAAP
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.62× | — | ||
| Q1 25 | -0.73× | -4.62× | ||
| Q4 24 | 0.45× | 2.40× | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | 1.42× | -2.64× | ||
| Q1 24 | -0.12× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADMA
| ADMA Bio Manufacturing Segment | $123.1M | 88% |
| Other | $16.0M | 12% |
AP
| Forged And Cast Mill Rolls | $67.0M | 64% |
| Air Handling Systems | $14.3M | 14% |
| Heat Exchange Coils | $13.1M | 13% |
| Centrifugal Pumps | $10.3M | 10% |
| Forged Engineered Products | $4.0M | 4% |
